Chris has an MS in Biomedical Engineering from the University of Wisconsin-Madison, and brings more than three years of advanced algorithms and big data research experience to EnsoData. He has acted as a leading contributor to the open source machine learning platform NEXT. Prior to EnsoData, Chris was CEO of a social custom apparel marketplace Langdon Co., where he grew the business and oversaw its successful acquisition within its first year.
Sam brings software engineering and leadership experience to EnsoData, previously holding positions at Hitachi, Innovative Signals Analysis, and the digital health startup, Branch2. Sam graduated with honors from the University of Wisconsin-Madison with a BS in Electrical and Computer Engineering, with a specialization in pattern recognition and signal processing. Sam transfers the most recent developments in big data and advanced algorithms to the clinical setting.
During his master's degree in Biomedical Engineering at the University of Wisconsin-Madison, Nick focused on the application of advanced algorithms to big medical data. Nick brings experience in scalable machine learning systems, wireless network streaming, and regenerative neurosurgery to EnsoData through positions he held at GE Healthcare, National Instruments, and the Nowak Optimization Lab. As CTO, Nick is principally responsible for the design and production deployment of amazing products and user experiences.
Mark has seen the peaks and valleys of starting, operating and assuming the risks of a new venture. He's come up against payroll, had a few bad hires and even swept the floors early on. Collectively, Mark's companies have done over $360 million in sales, raised more than $38 million in venture capital, and he has successfully bought and/or sold 8 companies. Among Mark's companies is Nordic Consulting, the industry leader in EHR consulting services to organizations using Epic. As CEO, Mark grew Nordic to a #1 ranking in KLAS, where it has been since 2012. Nordic now has over 400 consultants working across 44 states. In 2014, the company was recognized as the 46th fastest growing company in the U.S.
Dr. Robertson recently retired as Chief Executive Officer and Director of TomoTherapy Inc. Prior to joining TomoTherapy, Frederick served in a variety of roles in the medical field including Assistant Professor of Anesthesiology at the Medical College of Wisconsin, President and Chief Executive Officer of GE Marquette Medical Systems, and later as Chief Clinical Officer of GE Medical Systems. He also previously held management positions with Marquette Medical Systems, including President and Chief Executive Officer. He received his MBA from San Diego State University and earned his MD from University of Wisconsin Medical School. He serves on the University of Wisconsin Foundation Board of Directors, the Morgridge Institute for Research Board of Trustees and the Alpha Source, Inc. Board of Directors.
Robert Murtfeldt is a 30+ year veteran in the medtech and biotech industries. He has held executive leadership positions in world-class global healthcare companies - Johnson & Johnson, Medtronic and Baxter Healthcare. He has also been an entrepreneurial leader with a history of forming, financing and developing young healthcare businesses including Minimed (sold to Medtronic in 2001 for $3.7 Bil), Insulet (public company with $1.7 Bil market cap) and Neocrin (now ViaCyte). He is also a seasoned business development professional, experienced in evaluating, negotiating, closing and integrating a variety of transactions including M&A, partnerships and technology licensing. He holds technical degrees in Chemical Engineering and Biochemistry from the University of Wisconsin, and an MBA in Corporate Finance from the University of Southern California.
Olivia Rice is EnsoData's lead Medical Student Advisor, and keeps the team tuned in to the latest advancements from the frontlines of medicine and medical education. Olivia is currently a M3 at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. Her current research interests include Orthopaedic Surgery clinical trials and systematic reviews, in addition to finding innovative objective measures to replace subjective patient reporting in the field of Neuro-Ophthalmology. Previously, Olivia developed a strong technological background, graduating from the Biomedical Engineering program at UW-Madison in 2014, with an emphasis on biomaterials and computer science. While at UW, Olivia contributed to several biomedical research efforts and co-founded Mindful Health, where she lead development of cloud based applications for wirelessly streaming and analyzing pulse oximetry data from CHF patients at home. In this role at EnsoData, Olivia is constantly on the lookout for new opportunities in medicine where EnsoData's advanced algorithms, high performance computing, big data, and signal processing capabilities can be put to work to automate and simplify challenging and complex medical processes.